Host control comprises the immune reactions of an infected host to an infection.
Detailed description
Host control can, for example, refer to the degree to which an individual is able to fight replication of an infecting virus. The extent of host control determines whether a virus elicits symptoms in the host at all.
Organ transplant patients usually have to take immunosuppressive drugs for the rest of their lives to prevent their bodies from rejecting the organs. This therapy suppresses the physiological immune response to tumors and infections. The therapeutic goal for this patient group is to achieve an ...
On 1 June 2024, Professor Marcus Altfeld, Coordinator of the research area HIV at the German Center for Infection Research (DZIF), became Scientific Director of the Leibniz Institute of Virology (LIV)
INCATE (the INCubator for Antibacterial Therapies in Europe) and Kineticos AMR Accelerator Fund I (KAMRA I), have announced the beginning of a new collaboration that aims to enhance the support for
INCATE, the INCubator for Antibacterial Therapies in Europe, and BIOASTER, the French Technology Research Institute, have announced this week the beginning of a new partnership that aims to improve
Every year at least 700,000 people die as a result of infection with antibiotic-resistant bacteria—a figure which according to WHO forecasts could rise to ten million people by 2050 without new
Please use image only in conjunction with press release.
Antibiotics affect the composition and dynamics of the gut microbiome. Treatment with antibiotics not only leads to a loss of biodiversity of microorganisms, but also often favours the selection of
It was previously believed that herpesviruses use certain body cells to replicate and other body cells to remain dormant, that is to remain inactive for a longer period of time. This dogma is now
The INCubator for Antibacterial Therapies in Europe, INCATE, aims to support innovators in the early stages of developing therapies in the field of antimicrobial resistance. The German Center for
Scanning electron micrograph: C. difficile cells were provided by Nicole Metzendorf from the Department of Microbial Physiology and Molecular Biology, Institute of Microbiology, and imaged by Rabea Schlüter, Imaging Center of the Department of Biology, University of Greifswald, Germany.
Please use this image only in connection with this press release.
Infections with the bacterium Clostridioides difficile (C. difficile for short) frequently recur due to permanent stages remaining in the intestine. A drug that also effectively combats the permanent
